FDA Says Manufacture Of Pfizer's Docetaxel,Injection,10 Mg/Ml Multiple Dose Onco-Tain Glass Fliptop Vial Novaplus Is Discontinued
June 24 (Reuters) - FDA:
FDA: MANUFACTURE OF PFIZER'S DOCETAXEL, INJECTION, 160 MG/16 ML (10 MG/ML) MULTIPLE DOSE ONCO-TAIN GLASS FLIPTOP VIAL NOVAPLUS DISCONTINUED- WEBSITE
FDA: MANUFACTURE OF PFIZER'S DOCETAXEL, INJECTION, 20 MG/2 ML (10 MG/ML) SINGLE DOSE ONCO-TAIN GLASS FLIPTOP VIAL NOVAPLUS DISCONTINUED- WEBSITE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

What Is Intel, and Is Its Stock Still a Worthwhile Investment?

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Tradingkey







